Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix To Present Quell 2.0 at DTxDM East: The Digital Therapeutics and Digital Medicine Event in Boston
WALTHAM, Mass. , Sept. 25, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today announced that it will showcase its latest product innovation, Quell ® 2.0 Wearable Pain Relief Technology™, during a workshop at DTxDM East, and will discuss using real world, patient generated data to
View HTML
Toggle Summary NeuroMetrix Reports Discussion of Quell Wearable Pain Relief Technology on the Fox Business Network
WALTHAM, Mass. , Sept. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that its President and CEO, Dr. Shai N. Gozani , yesterday participated in a discussion of the opioid crisis and the Company’s Quell ® Wearable Pain Relief Technology™ on Mornings with Maria on the Fox
View HTML
Toggle Summary NeuroMetrix To Introduce Quell 2.0: The Next Generation, Wearable Pain Relief Technology at PAINWeek 2018
Company will launch its latest innovation at national conference on pain management LAS VEGAS , Sept. 4, 2018 /PRNewswire/ -- Tomorrow at PAINWeek 2018, NeuroMetrix Inc. (Nasdaq: NURO) , will unveil its latest breakthrough for the treatment of chronic pain.
View HTML
Toggle Summary NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB
WALTHAM, Mass. , Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual Meeting of NEURODIAB held in Rome, Italy September 4-7 .
View HTML
Toggle Summary NeuroMetrix Reports Presentation of Clinical and Scientific Data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference
WALTHAM, Mass. , Aug. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that it will present three scientific posters at the upcoming PAINWeek 2018 National Pain Conference to be held in Las Vegas, NV, September 4-8. The PAINWeek 2018 Abstract Book may be accessed here
View HTML
Toggle Summary NeuroMetrix to Present at H.C.Wainwright & Co 20th Annual Global Investment Conference in New York City
Presentation Shifted to 10:00 am on September 6, 2018 WALTHAM, Mass. , Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C.Wainwright 20th Annual Global Investment Conference has been shifted to 10:00 am
View HTML
Toggle Summary NeuroMetrix Announces Participation at the 20th Annual Global Investment Conference in New York City September 4 - 6th, 2018
WALTHAM, Mass. , Aug. 23, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 20th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 4 - 6, 2018, at The St. Regis New York in New York City. Shai N. Gozani, M.D., Ph.D.,
View HTML
Toggle Summary NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare
WALTHAM, Mass. , Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported that it had achieved the second development milestone under its strategic collaboration with GSK Consumer Healthcare . A milestone payment of $3.8 Million was made by GSK.
View HTML
Toggle Summary NeuroMetrix Reports Q2 2018 Financial Results
Initial $3.8M Milestone Achieved under GSK Strategic Collaboration WALTHAM, Mass. , July 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial and business highlights for the quarter ended June 30, 2018 . The Company develops and markets novel therapies, based on
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call
WALTHAM, Mass. , July 12, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc.(NASDAQ:NURO) announced today that it plans to issue its 2018 second quarter financial results before the opening of the market on Thursday, July 19, 2018. The Company will host a conference call at 8:00 a.m., Eastern
View HTML